Results 161 to 170 of about 1,140,223 (331)

THE RESULTS OF TREATMENT FOR RENAL CELL CARCINOMA

open access: bronze, 1988
Yoshio Aso   +20 more
openalex   +2 more sources

Metastatic renal cell carcinoma mimicking pleural mesothelioma. [PDF]

open access: bronze, 1987
Douglas Taylor   +3 more
openalex   +1 more source

Mitochondrial Regulation of CD8⁺ T Cells: Mechanisms and Therapeutic Modulation

open access: yesAdvanced Science, EarlyView.
This article comprehensively explores the pivotal role of mitochondrial function in CD8⁺ T cell immunotherapy. It highlights how mitochondrial dynamics regulate T cell activation, differentiation, and persistence, and how mitochondrial dysfunction leads to immune exhaustion and impaired antitumor/antiviral responses.
Xu Chen   +7 more
wiley   +1 more source

Podocyte RIPK3 Deletion Improves Diabetic Kidney Disease by Attenuating NF‐κB p65 Driven Inflammation

open access: yesAdvanced Science, EarlyView.
Prevention and treatment of diabetic kidney disease (DKD) have become a major global public health challenge. This study shed new light on the underlying pathogenic mechanisms of podocyte injury in DKD and highlights the therapeutic potential of mitigating podocyte injury through inhibition of the RIPK3/NF‐κB p65‐mediated inflammatory response as a ...
Lu'an Li   +10 more
wiley   +1 more source

Cases - Renal cell carcinoma with remote testicular metastases. [PDF]

open access: yesCan Urol Assoc J
Sidhom K   +6 more
europepmc   +1 more source

RENAL CELL CARCINOMA WITH CONTRALATERAL ADRENAL METASTASIS

open access: bronze, 1983
Fujio Masuda   +4 more
openalex   +2 more sources

LncDARS‐AS1 Regulates ATP1A1 Stability and Enhances Na+/K+ ATPase Activity to Promote Osteosarcoma Metastasis

open access: yesAdvanced Science, EarlyView.
This study identifies LncDARS‐AS1 as a novel oncogenic regulator that stabilizes ATP1A1 and enhances Na⁺/K⁺ ATPase activity, promoting osteosarcoma metastasis. Targeting the LncDARS‐AS1/ATP1A1/NKA axis, including pharmacological inhibition with digoxin, offers promising opportunities for the development of new therapeutic strategies against ...
Mingxian Xu   +12 more
wiley   +1 more source

Genomic correlates of response to immune checkpoint therapies in clear cell renal cell carcinoma

open access: yesScience, 2018
Diana Miao   +25 more
semanticscholar   +1 more source

Beyond conventional immune-checkpoint inhibition — novel immunotherapies for renal cell carcinoma

open access: yesNature Reviews Clinical Oncology, 2021
D. Braun   +6 more
semanticscholar   +1 more source

Home - About - Disclaimer - Privacy